VERAPAMIL REVERSAL OF CLINICAL DOXORUBICIN RESISTANCE IN HUMAN CANCER - A WILSHIRE-ONCOLOGY-MEDICAL-GROUP PILOT PHASE-I-II STUDY

被引：65

作者：

PRESANT, CA

KENNEDY, PS

WISEMAN, C

GALA, K

BOUZAGLOU, A

WYRES, M

NAESSIG, V

机构：

[1] WILSHIRE ONCOL MED GRP INC,LOS ANGELES,CA

[2] ST VINCENTS MED CTR,ONCOL PROGRAM,LOS ANGELES,CA 90057

[3] QUEEN VALLEY HOSP,CANC PROGRAM,LOS ANGELES,CA

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1986年 / 9卷 / 04期

关键词：

D O I：

10.1097/00000421-198608000-00016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：355 / 357

页数：3

相关论文

共 9 条

[1] CHERVINSKY D, 1962, P AM ASS CANCER RES, V13, P56
[2] ACTIVE OUTWARD TRANSPORT OF DAUNOMYCIN IN RESISTANT EHRLICH ASCITES TUMOR-CELLS
DANO, K
[J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 323 (03) : 466 - 483
[3] INABA M, 1980, CANCER RES, V71, P343
[4] KAELIN WG, 1982, CANCER RES, V42, P3944
[5] REVERSAL OF ADRIAMYCIN RESISTANCE BY VERAPAMIL IN HUMAN OVARIAN-CANCER
ROGAN, AM
HAMILTON, TC
YOUNG, RC
KLECKER, RW
OZOLS, RF
[J]. SCIENCE, 1984, 224 (4652) : 994 - 996
[6] TRANSPORT AND BINDING OF DAUNORUBICIN, ADRIAMYCIN, AND RUBIDAZONE IN EHRLICH ASCITES TUMOR-CELLS
SKOVSGAARD, T
[J]. BIOCHEMICAL PHARMACOLOGY, 1977, 26 (03) : 215 - 222
[7] VERAPAMIL RESTORATION OF DAUNORUBICIN RESPONSIVENESS IN DAUNORUBICIN-RESISTANT EHRLICH ASCITES-CARCINOMA
SLATER, LM
MURRAY, SL
WETZEL, MW
WISDOM, RM
DUVALL, EM
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (05) : 1131 - 1134
[8] ENHANCEMENT OF VINCRISTINE-INDUCED AND ADRIAMYCIN-INDUCED CYTO-TOXICITY BY VERAPAMIL IN P388 LEUKEMIA AND ITS SUBLINES RESISTANT TO VINCRISTINE AND ADRIAMYCIN
TSURUO, T
IIDA, H
YAMASHIRO, M
TSUKAGOSHI, S
SAKURAI, Y
[J]. BIOCHEMICAL PHARMACOLOGY, 1982, 31 (19) : 3138 - 3140
[9] TSURUO T, 1982, CANCER RES, V42, P4730